Protect Pharmaceutical Current Valuation vs. Current Ratio
| PRTT Stock | USD 0.89 0.01 1.11% |
For Protect Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Protect Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Protect Pharmaceutical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Protect Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Protect Pharmaceutical over time as well as its relative position and ranking within its peers.
Protect |
Protect Pharmaceutical Current Ratio vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Protect Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Protect Pharmaceutical value to that of its competitors to determine the firm's financial worth. Protect Pharmaceutical is rated below average in current valuation category among its peers. It is rated below average in current ratio category among its peers . The ratio of Current Valuation to Current Ratio for Protect Pharmaceutical is about 6,504,282 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Protect Pharmaceutical's earnings, one of the primary drivers of an investment's value.Protect Current Valuation vs. Competition
Protect Pharmaceutical is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 1.19 Billion. Protect Pharmaceutical adds roughly 2.6 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Protect Current Ratio vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Protect Pharmaceutical |
| = | 2.6 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Protect Pharmaceutical |
| = | 0.40 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Protect Current Ratio Comparison
Protect Pharmaceutical is currently under evaluation in current ratio category among its peers.
Protect Pharmaceutical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Protect Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Protect Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of Protect Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of Protect Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. Protect Pharmaceutical Corporation was founded in 1987 and is based in Las Vegas, Nevada. Protect Pharmaceutical is traded on OTC Exchange in the United States.
Protect Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Protect Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Protect Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Protect Pharmaceutical's important profitability drivers and their relationship over time.
Use Protect Pharmaceutical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Protect Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protect Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Protect Pharmaceutical Pair Trading
Protect Pharmaceutical Pair Trading Analysis
The ability to find closely correlated positions to Protect Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Protect Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Protect Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Protect Pharmaceutical to buy it.
The correlation of Protect Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Protect Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Protect Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Protect Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Protect Pharmaceutical position
In addition to having Protect Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Beers Thematic Idea Now
Beers
Companies involved in production and distribution of domestic and international beer. The Beers theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beers Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Protect Pink Sheet Analysis
When running Protect Pharmaceutical's price analysis, check to measure Protect Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protect Pharmaceutical is operating at the current time. Most of Protect Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Protect Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protect Pharmaceutical's price. Additionally, you may evaluate how the addition of Protect Pharmaceutical to your portfolios can decrease your overall portfolio volatility.